1389264-17-8
Chemical Structure
Darapladib analog-1
- CAS No.: 1389264-17-8
- Formula:C36H38F4N4O2S
- Molecular Weight:666.77
IUPAC Name: N-(2-(diethylamino)ethyl)-2-((2-((4-fluorobenzyl)thio)-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)oxy)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide
InChIKey: KELIVYXNVITYCV-UHFFFAOYSA-N
SMILES: O=C(COC1=NC(SCC2=CC=C(C=C2)F)=NC3=C1CCC3)N(CCN(CC)CC)CC4=CC=C(C5=CC=C(C(F)(F)F)C=C5)C=C4
Biological Activity: Darapladib analog-1 (Compound 16) is an O-alkylated Darapladib (HY-10521). Darapladib analog-1 inhibits Lp-PLA2. Darapladib analog-1 can be used in the research of atherosclerosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Darapladib analog-1 | Darapladib analog-1 (Compound 16) is an O-alkylated Darapladib (HY-10521). Darapladib analog-1 inhibits Lp-PLA2. Darapladib analog-1 can be used in the research of atherosclerosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
